As seen for PTL and DMAPT, melampomagnolide B (MMB) showed anti-tumoral activity due to its ability to inhibit the NF-κB pathway by inhibiting IKKβ activation in several cancer cell lines [137,138]. This evidence concerns the gene NFKB1 and cancer.